180 Life Sciences CORP Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
Konstantin Lomashuk, a 10% owner of 180 Life Sciences Corp., sold 250,000 shares of common stock on July 21, 2026 for $6.00 per share.
Konstantin Lomashuk, a 10% owner of 180 Life Sciences Corp., sold 2,562 shares of common stock on July 15, 2026 for $6.30 per share.
Konstantin Lomashuk, a 10% owner of 180 Life Sciences Corp., sold 3,387 shares of common stock on July 9, 2026 for $6.15 per share.
Konstantin Lomashuk, a director and 10% owner of FORUM MARKETS Inc. (FRMM), reported the sale of 3,702 shares on July 7, 2026, and 1,100 shares on July 8, 2026.
Forum Markets Inc. director Angela Dalton has received a grant of 203,562 restricted stock units with vesting schedules extending through April 2027.
Michael Edwards, a Director at FORUM MARKETS Inc. (FRMM), has reported the acquisition of 203,562 shares of Common Stock, primarily through restricted stock units.
Andrew P. Suckling, a Director at Forum Markets Inc., has acquired 241,918 shares of common stock through restricted stock units.
Forum Markets Inc. Director Ryan Lewis Smith reported the acquisition of 241,918 shares of common stock on April 2, 2026, through restricted stock units.
FORUM MARKETS Inc. Chief Financial Officer, John Tazewell Saunders, reported a significant acquisition of 358,592 shares of common stock on April 2, 2026.
McAndrew Rudisill, CEO and Director of FORUM MARKETS Inc., reports significant changes in beneficial ownership of common stock, including performance-based and restricted stock units.
Director Jason New of Forum Markets Inc. reported the acquisition of 241,918 shares of common stock, with a portion tied to restricted stock units.
Director Crystal Heter reported the acquisition of 241,918 shares of common stock in Forum Markets Inc. (FRMM) on April 2, 2026.
ETHZilla Corp's director, Andrew P Suckling, had previously granted restricted common stock awards rescinded and cancelled effective ab initio.
ETHZilla Corp's director, Jason Griffin New, had his previously granted restricted common stock awards rescinded and cancelled effective ab initio.
ETHZilla Corp's Director, Crystal Jane Heter, had her previously granted restricted common stock awards rescinded and cancelled effective as of their original grant date.
ETHZilla Corp's Chief Financial Officer, John Tazewell Saunders, reported the acquisition of 109,312 common shares as compensation, with 23,447 shares withheld for tax obligations.
ETHZilla Corp Director Ryan Lewis Smith gifted 16,718 shares of common stock to an LLC he manages for estate planning purposes, with no change in beneficial ownership for Section 16 reporting.
ETHZilla Corp. director Ryan Lewis Smith's previously granted restricted common stock awards, totaling 16,718 shares, have been rescinded and cancelled.
ETHZilla Corp's CEO, McAndrew Rudisill, had his previously granted restricted common stock awards rescinded and cancelled effective from their original grant date.
ETHZilla Corp's CEO and Director, McAndrew Rudisill, reported recent acquisitions and dispositions of common stock, including a significant stock award and subsequent tax-related withholdings and estate planning gifts.
ETHZilla Director Crystal Jane Heter received a significant equity grant for her board services, partially offset by tax withholdings and a gift for estate planning purposes.
ETHZilla Corp Director Andrew P. Suckling reported the acquisition of 649,748 shares, tax-related disposition of 175,854 shares, and a gift of 149,020 shares for estate planning purposes.
ETHZilla Corp Director Ryan Smith reported acquiring shares for services, tax withholding, and an estate planning gift, resulting in a shift to indirect ownership.
ETHZilla Corp Director Jason New reported the acquisition of shares for services, tax-related dispositions, and transfers for estate planning purposes.
ETHZilla Corp CEO Blair Jordan filed a Form 4 detailing changes in his beneficial ownership, including the expiration of one voting agreement and the continuation of others.
Elray Resources, a former 10% owner of ETHZilla Corp, exercised warrants and sold millions of shares, effectively divesting its entire stake.
McAndrew Rudisill, Executive Chairman of 180 Life Sciences Corp., disclosed significant indirect beneficial ownership of common stock and warrants.
180 Life Sciences Corp. director Stephen H. Shoemaker reported beneficial ownership of common stock and a new grant of 181,422 non-qualified stock options.
180 Life Sciences Corp. director Ryan Lewis Smith was granted 771,044 non-qualified stock options with a $3.01 exercise price, contingent on stockholder approval.
180 Life Sciences CEO Blair Jordan acquired 771,044 non-qualified stock options and holds significant voting control over additional common shares through various agreements.